|
|
Article: HLA-omics and cancer biomarkers: emerging tools and technologies for the medical laboratory.(Disease/Disorder overview)
- Article from:
- Medical Laboratory Observer
- Article date:
- April 1, 2008
- Author:
CopyrightCOPYRIGHT 2008 Nelson Publishing. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CONTINUING EDUCATION
To earn CEUs, see current test at www.mlo-online.com under the CE Tests tab.
LEARNING OBJECTIVES
Upon completion of this article, the reader will be able to recognize:
1. the role of HLA class I molecules in immune surveillance.
2. the validation process for disease-related peptide biomarkers.
3. how validated peptide biomarkers can be employed in vaccine therapies.